Gene expression and copy number profiling5–7 or expression of marker proteins, like estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor 2, and marker of proliferation Ki-67, can be used to categorize breast cancers into biological subtypes with specific treatment recommendations and different estimates for patient survival8,9. This evidence concerns the gene PGR and breast cancer.